In vitro effects on tumor cells of macrophages isolated from an early-passage chemically-induced murine sarcoma and from its spontaneous metastases - PubMed (original) (raw)
In vitro effects on tumor cells of macrophages isolated from an early-passage chemically-induced murine sarcoma and from its spontaneous metastases
A Mantovani. Int J Cancer. 1981.
Abstract
Macrophages were isolated by adherence from an early-passage chemically-induced tumor in C57BL/6 mice and from its spontaneous lung metastases. Cytolytic activity was measured as release of [3H]-thymidine from prelabelled tumor cells and cytostasis in a postlabelling assay. Normal, unstimulated peritoneal macrophages exhibited low but significant non-specific cytotoxic activity at attacker to target (A:T) ratios greater than or equal to 20:1, whereas stimulation of tumor-cell proliferative capacity was consistently observed at A:T ratios less than or equal to 2.1, Macrophages from the peritoneal cavity of tumor-bearing mice, from the primary tumor or from polled secondaries had baseline cytotoxic or growth-enhancing (depending on the A:T ratio) potential similar to that of control peritoneal macrophages. In vitro exposure to endotoxin, lymphokine supernatants or partially purified fibroblast interferon augmented the tumoricidal activity of normal and tumor-associated macrophages; tumor-associated macrophages showed no evidence of enhanced responsiveness to these activating stimuli. Tumor cells from the primary neoplasm and its spontaneous metastases were equally susceptible to macrophage tumoricidal activity. It is inferred from in vitro data that the relatively low numbers of non-activated macrophages present within poorly immunogenic metastasizing tumors may have no direct effect or actually stimulate tumor-cell proliferative capacity at the primary tumor site; conversely, disseminating tumor cells might encounter sufficient numbers of mononuclear phagocytes in the circulation and in lungs to permit the expression of macrophage cytotoxicity, at least during the early steps of metastasis formation.
Similar articles
- Macrophages in cancer metastases and their relevance to metastatic growth.
Key ME. Key ME. Cancer Metastasis Rev. 1983;2(1):75-88. doi: 10.1007/BF00046906. Cancer Metastasis Rev. 1983. PMID: 6352008 Review. - Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin.
Peri G, Polentarutti N, Sessa C, Mangioni C, Mantovani A. Peri G, et al. Int J Cancer. 1981 Aug 15;28(2):143-52. doi: 10.1002/ijc.2910280206. Int J Cancer. 1981. PMID: 6172388 - Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.
Bordignon C, Avallone R, Peri G, Polentarutti N, Mangioni C, Mantovani A. Bordignon C, et al. Clin Exp Immunol. 1980 Aug;41(2):336-42. Clin Exp Immunol. 1980. PMID: 6160006 Free PMC article. - Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma.
Mantovani A, Giavazzi R, Alessandri G, Spreafico F, Garattini S. Mantovani A, et al. Eur J Cancer (1965). 1981 Jan;17(1):71-6. doi: 10.1016/0014-2964(81)90213-9. Eur J Cancer (1965). 1981. PMID: 7262148 No abstract available.
Cited by
- Cancer researchers get a grip on immune cell plasticity.
Marx V. Marx V. Nat Methods. 2021 Apr;18(4):337-341. doi: 10.1038/s41592-021-01112-8. Nat Methods. 2021. PMID: 33772243 No abstract available. - Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.
Negus RP, Stamp GW, Hadley J, Balkwill FR. Negus RP, et al. Am J Pathol. 1997 May;150(5):1723-34. Am J Pathol. 1997. PMID: 9137096 Free PMC article. - Macrophages in cancer metastases and their relevance to metastatic growth.
Key ME. Key ME. Cancer Metastasis Rev. 1983;2(1):75-88. doi: 10.1007/BF00046906. Cancer Metastasis Rev. 1983. PMID: 6352008 Review. - Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients.
Sheid B, Boyce J. Sheid B, et al. Cancer Immunol Immunother. 1984;17(3):190-4. doi: 10.1007/BF00205484. Cancer Immunol Immunother. 1984. PMID: 6332671 Free PMC article. - Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity.
Urban JL, Schreiber H. Urban JL, et al. J Exp Med. 1983 Feb 1;157(2):642-56. doi: 10.1084/jem.157.2.642. J Exp Med. 1983. PMID: 6185615 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical